Toward imaging of alpha-synuclein with PET
2023-03-03 07:20KejalKantarcietal
四川生理科学杂志 2023年9期
Kejal Kantarci , et al
Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.
- 四川生理科学杂志的其它文章
- 罗哌卡因复合舒芬太尼硬膜外麻醉在无痛分娩中的麻醉、镇痛作用分析
- “动物生理学”课程融入思政教育的实践与思考#
- The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9
- Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study
- PINK1, Keap1, and Rtnl1 regulate selective clearance of endoplasmic reticulum during development
- Will climate change amplify epidemics and give rise to pandemics